TAG:
ehi
Royal Free Hospital Is First Big British Lab Automation Project
By Robert Michel | From the Volume X No. 4 – March 24, 2003 Issue
CEO SUMMARY: To date, only a handful of total laboratory automation (TLA) projects have been implemented in Great Britain. One of those first TLA projects is at the Royal Free Hospital, Hampstead, located in the northern suburbs of London. Design work started in 1998 and the first phase b…
Several Major Surprises Mark Events of 2002
By Robert Michel | From the Volume IX No. 17 – December 9, 2002 Issue
CEO SUMMARY: It was a year when the two blood brothers got much bigger and expanded market share by buying their largest competitors. With patient safety as the goal, employers began active steps to force hospitals, physicians, and other healthcare providers to use quality management syst…
Another Lab Acquisition: LabCorp To Buy DIANON
By Robert Michel | From the Volume IX No. 16 – November 18, 2002 Issue
CEO SUMMARY: Laboratory Corporation of America Holdings will pay almost $598 million to buy DIANON Systems, Inc. of Stratford, Connecticut. With this move, anatomic pathology becomes a high profile growth target for LabCorp. During the past eight years, DIANON Systems has built a national…
Disease Management Relies On Lab Testing
By Robert Michel | From the Volume IX No. 15 – October 28, 2002 Issue
CEO SUMMARY: Predictions are that 30% of large corporations will offer disease management programs for their employees by the end of next year. Disease management seems to be the next form of managed care, where prevention and early detection are the primary goals. Laboratories should be …
Quiet Progress on the Med Tech Supply Crisis
By R. Lewis Dark | From the Volume IX No. 14 – October 7, 2002 Issue
QUIETLY, WITHOUT MUCH FANFARE, a growing number of laboratory administrators and pathologists are taking action to increase the supply of med techs in their community. It’s the unpublicized response to the headlines about the impending mass retirement of baby-boomer MTs and MLTs. This is a notewor…
Quest & LabCorp Encounter Different Business Hurdles
By Robert Michel | From the Volume IX No. 14 – October 7, 2002 Issue
IT’S BEEN TOUGH SLEDDING in recent months for both Laboratory Corporation of America and Quest Diagnostics Incorporated. THE DARK REPORT believes there may be significance in these developments. Both national labs find themselves confronted with unexpected obstacl…
Removing Lab Players From the Chessboard
By R. Lewis Dark | From the Volume IX No. 13 – September 16, 2002 Issue
IN 1997-98, CEO Ken Freeman of Quest Diagnostics Incorporated made a keen insight about the commercial lab marketplace. At that time the three blood brothers—Laboratory Corporation of America, Quest Diagnostics, and SmithKline Beecham Clinical Laboratories…
Non-Pathologists Altering U.S. Laboratory Industry
By Robert Michel | From the Volume IX No. 13 – September 16, 2002 Issue
CEO SUMMARY: It’s an interesting contradiction. On one hand, most pathologists enthusiastically recognize the value that diagnostic testing services provide to the healthcare community. On the other hand, too often it is non-laboratorians who provide the investment capital and entrepren…
Changes Expected in Market For Hospital Reference Testing
By Robert Michel | From the Volume IX No. 13 – September 16, 2002 Issue
CEO SUMMARY: For the hospital send-out testing marketplace, 2002 has been an eventful year. First came the acquisition of American Medical Laboratories by Quest Diagnostics Incorporated. In April, Specialty Laboratories disclosed its problems with state and federal laboratory regulators. …
United Kingdom Soon to Tackle Consolidation of Hospital Labs
By Robert Michel | From the Volume IX No. 10 – July 15, 2002 Issue
CEO SUMMARY: Consolidation and regionalization of hospital laboratory testing are not isolated phenomenons. Beginning in the late 1980s, individual provinces in Canada began to rationalize lab testing services by building core labs and consolidating lab services across multiple hospitals….
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized